Vicki Goodman

Vicki Goodman

Chief Tech/Sci/R&D Officer at RECURSION PHARMACEUTICALS, INC.
57 year
Health Technology
Consumer Services
Government

Profile

Vicki L.
Goodman
is currently Chief Medical Officer at Recursion Pharmaceuticals, Inc. since 2026.
Former positions include Chief Medical Officer at Mural Oncology Plc from 2023 to 2025, Chief Medical Officer and EVP-Product Development at Exelixis, Inc. from 2022 to 2023, VP-Clinical Research and Head-Therapeutic Area at Merck & Co., Inc. from 2020 to 2021, VP and Head-New Asset Development at Bristol Myers Squibb Co. from 2015 to 2020, and Medical Officer in the Oncology Division at the US Food & Drug Administration from 2004 to 2007.
Education includes undergraduate studies at Rutgers State University of New Jersey and a doctorate from Albert Einstein College of Medicine, Inc.

Vicki Goodman active positions

CompaniesPositionStart
RECURSION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2026-04-05

Former positions of Vicki Goodman

CompaniesPositionEnd
EXELIXIS, INC. Chief Tech/Sci/R&D Officer 2023-08-22
MERCK & CO., INC. Chief Tech/Sci/R&D Officer 2021-11-30
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 2020-04-30
Corporate Officer/Principal 2006-12-31
See the detail of Vicki Goodman's experience

Training of Vicki Goodman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Government

Consumer Services